Half of these patients required support by mechanical ventilation (mean duration 7.3 days) and vasoactive drugs and 6% of patients received renal replacement.
Patients having a VAP had a longer ICU stay (mean extra length of stay: 4.2 days, for patients survivors from ICU) and a longer mechanical ventilation (mean extra duration: 1.7 days, for patients extubated).
Unroe et al. reported that at 1 year, average critically ill patients receiving prolonged mechanical ventilation (mean age 55 ± 16 years) spent 74% of all days alive in a hospital postcare facility or receiving home health care [22].
Barnato et al. showed that critically ill patients undergoing mechanical ventilation (mean age 76 ± 7 years) are more likely to suffer from greater disability compared with an age- and gender-matched population who incur hospitalization or not [19].
The mechanical ventilation mean time was 164.7 hours.
Sixty patients (34 with sepsis and 26 without) on mechanical ventilation, mean age 51 ± 19.6 years, mean ICU stay 24 ± 18.8 days, APACHE II score 13 ± 6.8, admitted directly to our ICU were enrolled in our study.
Seven patients (50%) required endotracheal intubation and mechanical ventilation (mean ± SD time from hospitalization to intubation 4.6 ± 1.8 [range 3 7] days), and 5 (36%) required tracheostomy and gastric feeding tube placement.
Barnato et al. showed that critically ill patients undergoing mechanical ventilation (mean age 76 ± 7 years) are more likely to suffer from greater disability compared with an age- and gender-matched population who incur hospitalization or not [ 19].
Unroe et al. reported that at 1 year, average critically ill patients receiving prolonged mechanical ventilation (mean age 55 ± 16 years) spent 74% of all days alive in a hospital postcare facility or receiving home health care [ 22].
DU ratios for mechanical ventilation (mean 0.73 [91,911 ventilator days in 126,315 patient days], p < 0.001) and central line catheterization (mean 0.71 [89,504 central line days in 126,315 patient days], p < 0.001) increased especially after 2005, but the incidence of VAP decreased until 2005 and then remained stable (p < 0.001) (Table 1 and Figure 1).
